The information in the press releases on these pages was factually accurate on the date of publication. These press releases remain on this Web site for historical purposes only. CIBA VISION assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.
Released 02/28/2008
ANDREA SAIA NAMED CIBA VISION CEO
Atlanta, Feb. 28 2008 – The Novartis Consumer Health Division is pleased to announce the appointment of Andrea Saia as CEO of CIBA VISION effective immediately. Prior to her appointment, Andrea was COO of CIBA VISION and has held several global positions of increasing responsibility within the company. Andrea succeeds Michael Kehoe, who has decided to pursue outside career opportunities. Novartis and CIBA VISION thank Michael Kehoe for his leadership and great commitment to CIBA VISION, and wish him much success with his future endeavors.
About CIBA VISION
With a focus on innovation, quality and strong partnerships with eye care practitioners, CIBA VISION is a global leader in the research, development and manufacturing of contact lenses and lens care products. CIBA VISION shares eye care practitioners' passion for healthy vision and dedication to improving the quality of patients’ lives around the world. With worldwide headquarters in Atlanta CIBA VISION is the eye care unit of Novartis AG (NYSE: NVS). For more information, visit the CIBA VISION web site at www.cibavision.com.